Moreover, Activin A receptor, type II (ACVR2) was among the most significantly downregulated genes (−0.88-fold; p ≤ 0.002) in GNE myopathy (Eisenberg et al., 2008; Table S1 in Supplementary Material). The gene discussed is ACVR2A; the disease is GNE myopathy.